A Study of AK117 in Combination With Azacitidine in Patients With Myelodysplastic Syndromes Read more about A Study of AK117 in Combination With Azacitidine in Patients With Myelodysplastic Syndromes
Early Feasibility Study of the Supira System in Patients Undergoing HRPCI Read more about Early Feasibility Study of the Supira System in Patients Undergoing HRPCI
Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease Read more about Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease
Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial) Read more about Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
A Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autoleucel Versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Autologous Stem Cell Transplant (ASCT) in Participants With Read more about A Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autoleucel Versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Autologous Stem Cell Transplant (ASCT) in Participants With
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia Read more about A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders Read more about ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis Read more about A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1 Read more about A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1